Biotech Stocks: Genzyme leads drug stocks higher (at MarketWatch)

Published Aug. 30, 2010 at 2:45 p.m.
Genzyme Corp. was the lead advancer among the large-cap drug stocks in early trading, with shares rising almost 4% to $70.16.


Back | Read more at Yahoo Finance US Markets